The Report Covers Global Intrauterine Contraceptive Devices Market Analysis and is Segmented by Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Device (IUD), and Other Types), Gender (Male and Female) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The value is provided in terms of (USD million) for the above segments.

The global contraceptive devices market size reached USD 15.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The increasing awareness about the importance of family planning, the growing incidence of unintended pregnancies, and the rising government initiatives and funding to promote family planning programs represent some of the key factors driving the market.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 15.0 Billion
Market Forecast in 2033	USD 23.1 Billion
Market Growth Rate (2025-2033)	4.9%

IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive devices market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on device type, end user and distribution channel.

The Market is Segmented by Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUD), and Implants) and Gender

For 2024, the contraceptive devices market in the United States was estimated at around five billion U.S. dollars. This statistic presents forecasts of the contraceptive devices market in the U.S. for 2024 and 2029.

United States Contraceptive Devices Market is segmented By Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra-Uterine Device (IUD) and Others), By Gender and Geography. The market provides the value (in USD million) for the above-mentioned segments.

The contraceptive devices market size was valued at USD 12.93 billion in 2024 and is likely to cross USD 26.58 billion by 2037, expanding at more than 5.7% CAGR during the forecast period i.e., between 2025-2037. Asia Pacific industry is expected to dominate majority revenue share by 2037, on the back of increasing population in the region.

Explore the Contraceptive Devices Market trends! Covers key players, growth rate 6.4% CAGR, market size $17.47 Billion, and forecasts to 2033. Get insights now!

Snapshot img

Intrauterine Contraceptive Devices (IUD) Market Size 2024-2028

The intrauterine contraceptive devices (IUD) market size is forecast to increase by USD 1.11 billion at a CAGR of 4.36% between 2023 and 2028. The market is experiencing significant growth due to several key factors. The increasing number of unintended pregnancies and unwanted abortions in the US continues to drive market demand. IUDs offer long-term efficacy and increased acceptance among women, making them a popular choice for birth control. However, the market also faces challenges related to adverse effects, such as those caused by prostaglandins during IUD insertion. White blood cells in the woman's uterus play a role in the body's response to IUDs, and ongoing research aims to improve our understanding of this interaction to enhance safety and efficacy. In summary, the IUD market is expanding due to its effectiveness and long-term benefits, while challenges remain related to adverse effects and ongoing research to improve safety and patient experience in health care services.

Request Free Sample

The intrauterine contraceptive devices (IUDs) market has gained significant attention in the US due to their effectiveness in preventing unplanned pregnancies among various demographics, particularly adolescents. IUDs are small, T-shaped devices that are inserted into the uterus to prevent sperm from reaching the egg and fertilizing it. Unplanned pregnancies can lead to several negative consequences, including discontinuation of schooling, financial burdens, and emotional stress.

Moreover, the IUDs offer a long-term, reversible, and highly effective solution to this issue. Hospitals and clinics play a vital role in the dissemination of IUDs as they provide easy access to these devices for women. The high prevalence of IUDs in hospitals and clinics is a testament to their growing popularity as a reliable contraceptive method.

Furthermore, the affordability of IUDs is a current trend in the market, as many insurance plans cover the cost of these devices. This affordability factor, combined with the convenience and long-term effectiveness of IUDs, makes them an attractive option for women seeking reliable birth control methods. Currently, there are over 7 million IUD users in the US, with an estimated growth rate of 3.5% per year. This growth can be attributed to the increasing awareness of IUDs as a safe and effective contraceptive method, as well as their long-term use, which reduces the need for frequent refills or replacements.

Similarly, the prostaglandins, white blood cells, and hormones are essential components of IUDs, as they contribute to their mechanism of action. Prostaglandins are responsible for initiating uterine contractions during labor, while white blood cells help prevent infections. Hormones, such as progesterone, are released by hormonal IUDs to prevent ovulation and thicken cervical mucus. Community healthcare initiatives have played a crucial role in increasing the adoption of IUDs, particularly among underserved populations. These initiatives aim to provide accessible and affordable family planning resources to women, reducing the number of unplanned pregnancies and improving overall public health. In conclusion, the intrauterine contraceptive devices (IUDs) market in the US continues to grow due to their effectiveness, affordability, and long-term use. Hospitals, clinics, and community healthcare initiatives play a vital role in increasing awareness and accessibility to these devices, ultimately contributing to a reduction in unplanned pregnancies and improved family planning outcomes.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Hormonal intrauterine device
  Copper intrauterine device


End-user

  Hospitals
  Gynecology clinics
  Others


Geography

  North America

    US


  Europe

    Germany
    France


  Asia

    China
    Japan


  Rest of World (ROW)

By Type Insights

The hormonal intrauterine device segment is estimated to witness significant growth during the forecast period. Intrauterine contraceptive devices (IUDs) that release the hormone progestin are an effective method for preventing unwanted pregnancies. These devices work by inhibiting ovulation and thickening cervical mucus, preventing sperm from reaching the egg. Hormonal IUDs offer additional benefits, including a reduced risk of pelvic inflammatory disease (PID) and tubal pregnancies. Furthermore, they can help alleviate symptoms associated with conditions such as polycystic ovary syndrome (PCOS) and endometriosis. Compared to copper IUDs, hormonal IUDs have fewer complications and risks. The increase in awareness and acceptance of IUDs as a re

The French Contraceptive Devices Market is Segmented by Product Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUD), and Other Product Types) and Gender (Male and Female). The report offers the value (in USD million) for the above segments.

The size and share of the market is categorized based on Application (Hospitals, Pharmacies) and Product (Oral, Vaginal, Injectable Contraceptive Drugs, Male/Female Contraceptive Devices) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The size and share of the market is categorized based on Type (Male Contraceptive Devices, Female Contraceptive Devices) and Application (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Online Pharmacy, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The contraceptive market is anticipated to be valued at US$ 19.79 billion in 2024 and registering a CAGR of 5.5% from 2024 to 2034. The market is foreseen to reach US$ 33.79 billion by 2034.

Attributes	Details
Market Value for 2024	US$ 19.79 billion
Market Value for 2034	US$ 33.79 billion
Market Forecast CAGR for 2024 to 2034	5.5%

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projection

Attributes	Details
Market Historical CAGR for 2019 to 2023	3.90%

Category-wise Insights

Attributes	Details
Top Product Type	Drug
Market share in 2024	41.50%

Attributes	Details
Top Gender	Female
Market share in 2024	74.70%

Country-wise Insights

Countries	CAGR from 2024 to 2034
United States	5.80%
Germany	5.50%
China	6.10%
India	5.80%
Australia and New Zealand	5.10%

Technological advancements in the North America Contraceptive Drugs and Devices industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are transforming industry practices, offering a comprehensive outlook on future opportunities and market potential.

The Asia-Pacific contraceptive drugs and devices market is anticipated to grow from USD XX million in 2025 to USD XX million by 2033, registering a CAGR of 6.39% during the forecast period (2025-2033). The growth of the market is attributed to factors such as rising awareness about family planning, the increasing prevalence of sexually transmitted diseases, and government initiatives promoting the use of contraceptives. China, India, and Japan are the major contributors to the growth of the market in the region. Increasing demand for long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and contraceptive implants, is a significant trend in the Asia-Pacific contraceptive drugs and devices market. The growing popularity of these methods is due to their high efficacy, convenience, and long-term protection against pregnancy. Additionally, technological advancements in the development of new and innovative contraceptive devices, such as self-injectable contraceptives and biodegradable implants, are expected to further drive the market growth in the coming years. Key drivers for this market are: , Increasing Incidence of the STDs; Increasing Rate of Unintended Pregnancies; Rise in Government Initiatives. Potential restraints include: , High Cost of Devices and Treatment; Side Effects Associated with the Use of Contraceptive Drugs and Devices. Notable trends are: Oral Contraceptive Segment is Expected to Hold the Largest Market Share in the Asia-Pacific Contraceptive Market.

The size of the Germany Contraceptive Devices Market was valued at USD 539.00 Million in 2023 and is projected to reach USD 815.82 Million by 2032, with an expected CAGR of 6.10% during the forecast period. Different devices in the German Contraceptive Devices market, like condoms, diaphragms, implants, and intrauterine devices (IUDs), are used to prevent pregnancy. These tools are necessary for managing family planning and sexual health, providing effective, reversible, and long-lasting contraceptive choices. Growing awareness of contraceptive methods, government efforts to promote family planning, and a rising popularity of long-acting reversible contraceptives are all contributing to driving the market. Bayer AG, CooperSurgical Inc., and AbbVie Inc. (Allergan) are key contenders in the industry, commanding the market with varied product offerings and robust distribution channels. Focusing on decreasing unintentional pregnancies and enhancing reproductive health services contributes to the expansion of the market. Although facing obstacles like regulatory issues and cultural challenges, the market's optimistic prospects are supported by continuous research and development endeavors, underscoring the vital importance of contraceptive devices in Germany's healthcare industry. Recent developments include: October 2022: Bayer's long-acting reversible intrauterine system (IUS), Mirena (levonorgestrel (LNG) releasing IUS), received regulatory approval through the European Workshare Procedure for up to eight years of use as a contraceptive., January 2022: Nuvo Group announced its partnership with Charité Universitätsmedizin Berlin to introduce the advantages of remote pregnancy monitoring to Europe for the first time. The collaboration aims to lay the foundation for the future use of predictive analytics to improve health outcomes.. Key drivers for this market are: Increasing Awareness about Sexually Transmitted Diseases (STDs), Rising Rate of Unintended Pregnancies. Potential restraints include: Side Effects Associated with the Use of Contraceptive Devices. Notable trends are: Intra Uterine Device (IUD) is Estimated To Grow at a High Rate During The Forecast Period.

The size of the Spain Contraceptive Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 7.90% during the forecast period. The market for Contraceptive Devices in Spain consists of a range of devices like condoms, diaphragms, implants, and IUDs, which are used to avoid pregnancy. These tools are crucial for managing family size and sexual well-being, providing reliable, temporary, and extended birth control choices. Growing awareness of contraceptive methods, government programs supporting family planning, and a rising inclination towards long-acting reversible contraceptives are fueling the market. Key companies such as Bayer AG, CooperSurgical Inc., and AbbVie Inc. (Allergan) lead the market with varied product offerings and robust distribution channels. The focus on decreasing unintended pregnancies and enhancing reproductive health services contributes to the growth of the market. Despite obstacles like regulation and cultural differences, ongoing research and development efforts are boosting the market's optimistic future, underscoring the vital importance of contraceptive devices in Spain's healthcare system. Recent developments include: October 2022: Bayer AG launched its Mirena intrauterine device (IUD) for extended duration of use in contraception in Europe after it received EU approval., May 2022: Perrigo Company plc completed the acquisition of HRA Pharma. HRA Pharma is a leading provider of intrauterine (IUD) devices, and it has a presence in Spain.. Key drivers for this market are: Increasing Prevalence of Sexually Transmitted Diseases and Rising Awareness About Them, Rise in Government Initiatives. Potential restraints include: Side Effects Associated with the Use of Contraceptive Devices. Notable trends are: Condom is Expected to Witness High Growth Over the Forecast Period.

The market size of the Contraceptives Devices Market is categorized based on Application (Hospital, Pharmacy, Other) and Product (Condoms, Diaphragms, Sponges, Other) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

This report provides insights into the market size and forecasts the value of the market, expressed in USD million, across these defined segments.

The Chinese Contraceptive Devices Market is Segmented by Product Type (Condoms, Diaphragms, Intrauterine Devices, and Other Product Types) and End User (Female and Male). The report offers the value (USD million) for the above segments.

The size of the Australia Contraceptive Devices market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 7.91% during the forecast period.These are birth control weapons and techniques, which avoid pregnancy. They can stop the sperm from reaching the egg or refuse an already fertilized egg to attach on the uterus. Among the contraceptive devices, an individual has various alternatives that can match his preference and needs, including condoms, intrauterine devices, diaphragms, and contraceptive implants. Such factors as heightened awareness of sexual health, growing cases of STIs, and governmental encouragement of family planning affect the demand for contraceptive devices in Australia. More likely to go up the next few years, more individuals will seek effective uncomplicated contraceptive methods. Major market trends in Australia primarily characterize a strong shift towards LARCs, which include IUDs and implants, mainly because of high efficacy with minimum user intervention. Simultaneously, over-the-counter sales of contraceptive devices such as condoms and emergency contraception are also increasing, which would make a significant contribution to the growth of the market. Advancement in contraceptive technology, particularly new formulations of IUDs and enhanced implant designs, are also growth drivers. Further, a rise in the incidence of STIs is fueling up the demand for the same as these products help in preventing pregnancy, but more importantly, will also prevent the setting up of STIs. The Australian contraceptive devices market would see significant growth and expansion due to several factors in the form of increasing awareness, government initiatives, and availability of novel technologies. The future will look towards a growing demand for efficient and convenient means of contraception. Recent developments include: May 2022: Moments Condoms revealed that it would be one of the first Australian condom brands aimed solely at women to be offered in over 600 Coles supermarkets across the country. Moments Condoms will unveil its new Ultra Thin range, which claims more lubrication and is available in three sizes: ordinary, big, and extra large, as a result of the collaboration., April 2022: Family Planning NSW launched the Freedom Condom project, which will provide free condoms, water-based lubricants, and sexual health information to under-30s across the state.. Key drivers for this market are: Rising Cases of Sexually Transmitted Diseases, Government Initiatives Regarding Usage of Contraceptive Devices. Potential restraints include: Side Effects Associated with Contraceptive Devices. Notable trends are: Condoms is Expected to Exhibit a Steady Growth During the Forecast Period.

The size and share of the market is categorized based on Application (Hospitals, Gynaecology Clinics, Community Healthcare) and Product (Copper IUCD, Hormonal IUCD) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).